Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2020 May 7;395(10235):1469–1471. doi: 10.1016/S0140-6736(20)31027-8

Reconnecting for our future: The Lancet One Health Commission

John H Amuasi a,b, Tamara Lucas c, Richard Horton c, Andrea S Winkler d,e
PMCID: PMC7252112  PMID: 32386579

The evolution and sustenance of our planet hinges on a symbiotic relationship between humans, animals, and the environment that we share—we are interconnected. However, this past century has seen human dominance over the biosphere, manifest in technological innovations, accelerated mobility, and converted ecosystems that characterise industrialisation, globalisation, and urbanisation.1 These developmental trajectories have advanced human health in unprecedented ways. However, they also make humans increasingly vulnerable to contemporary global health challenges, such as emerging and re-emerging infectious diseases,2 as shown by the coronavirus disease 2019 (COVID-19) pandemic, antimicrobial resistance (AMR),3 and the increasing burden of non-communicable diseases.4 These challenges are further impacted by climate change, poverty, conflict, and migration.5

The apparent dominance of the human species comes with a huge responsibility. Thus, in our quest to ensure the health and continued existence of humanity, consideration must be given to the complex interconnectedness and interdependence of all living species and the environment—the concept of One Health.6, 7, 8 One Health highlights the synergistic benefit of closer cooperation between the human, animal, and environmental health sciences, as well as the importance of dismantling disciplinary and professional silos. The One Health concept has been recognised and promoted by the UN, the G20, and WHO, among several others.9 The Sustainable Development Goals in themselves can be understood as embodying a One Health strategy aimed at healthy people living on a perpetually habitable planet.10

The Lancet One Health Commission comprises 24 Commissioners (appendix) and several researchers from multiple disciplines from around the globe. The Commission's inaugural meeting was held in Oslo, Norway, in May, 2019. The Centre for Global Health at the University of Oslo, Norway, hosts the northern secretariat, with the support of the Center for Global Health at the Technical University of Munich, Germany. The Global Health group at the Kumasi Centre for Collaborative Research in Tropical Medicine on the Kwame Nkrumah University of Science and Technology campus, Kumasi, Ghana, hosts the southern secretariat. The Lancet One Health Commission aims for transdisciplinary and interdisciplinary collaboration to promote original thinking and generate solutions to the complex global health challenges of modern times, most of which require a One Health approach. The Commission's work is expected to offer a recalibrated understanding of the ways in which these global health challenges are implicated within the complex interconnectedness of humans, animals, and our shared environment, and to provide an approach for harnessing this knowledge to ensure a sustainably healthy future for all species, and the planet we inhabit.

The main objective of The Lancet One Health Commission is to synthesise the evidence supporting a One Health approach to enhancing health within an environment shared by humans and animals. The Commission's work will explicate the significance of a One Health approach for policy by engaging transdisciplinary expertise and perspectives from both the public and private sectors. The Commission will explore global health challenges through a One Health lens,11 directing attention to infectious diseases, AMR, and non-communicable diseases—the latter of which have often been left out of the discourse on One Health.

In proposing policy, implementation, and governance recommendations, the Commission will emphasise sociopolitical dimensions of health that are crucial for engaging and educating communities. Similarly, the Commission will promote leadership to build consensus among disparate sectors and foster champions for cohesion and change. Novel financing mechanisms will be assessed because these are key for building resilient health systems nationally and internationally.12 Conclusions from the Commission are anticipated to be integrated in policy briefs, international guidelines and protocols, and various high-level global health resolutions.

At the core of The Lancet One Health Commission's work is our recognition of several possible approaches to examining the animal–environment–human interface, which we distil into three distinct but interrelated dimensions (figure ).

Figure.

Figure

Approach of The Lancet One Health Commission

The first dimension is the shared environment. We will consider how animals, including livestock, wildlife, and companions, share a common environment with humans in both rural and urban settings. We further explore the positive and negative implications of human activities and human–animal interactions for the shared environment. Within this space, zoonotic and emerging infectious diseases, as well as non-communicable diseases and mental health, will be considered.

The second dimension is safe food and food systems. People rely on animals both as food and to help produce food. As such, the link between One Health and food safety and security will be explored. Among other things, the Commission will critically examine evidence for the hypothesised link between AMR and agricultural practices and we will proffer policy recommendations for scientific work to measure the association using innovative research methods.13, 14

The third dimension is shared medicines and interventions. Several drugs used to treat health conditions in humans originated from animal agriculture—eg, praziquantel15 and ivermectin.16 The potential for a more integrated approach to the implementation of health interventions that target both animals and people will be explored.

Each of these three dimensions will be examined in relation to infectious diseases, non-communicable diseases, and AMR (figure). Operationalising One Health will require integrated animal and human health systems, including surveillance; robust modelling efforts that use big data for animals, humans, and plants; and engagements with digital health. Now more than ever with the COVID-19 pandemic, concerted knowledge and evidence generation must inform and catalyse responsive leadership, context-driven governance, progressive policy, and legislation that are sensitive to gender, community, equity, and ethics (figure). This work is vital for ensuring a sustainably reconnected approach to defending and synergistically enhancing the health of humans, animals, and our shared environment.

Acknowledgments

We declare no competing interests. The Lancet One Health Commission receives funding from the German Federal Ministry of Education and Research (01KA1912) and the Life Science Programme at the University of Oslo. We thank Christina Brux for her help in preparing this Comment.

Supplementary Material

Supplementary appendix
mmc1.pdf (67.2KB, pdf)

References

  • 1.Schmidt-Bleek F. Springer; Birkhäuser Basel: 1994. Wieviel umwelt braucht der mensch?: MIPS—das maß für ökologisches wirtschaften. (in German) [Google Scholar]
  • 2.Klohe K, Amuasi J, Kaducu JM. The 2017 Oslo conference report on neglected tropical diseases and emerging/re-emerging infectious diseases—focus on populations underserved. Infect Dis Poverty. 2019;8:40. doi: 10.1186/s40249-019-0550-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109:309–318. doi: 10.1179/2047773215Y.0000000030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.GBD 2017 DALYs and HALE Collaborators Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1859–1922. doi: 10.1016/S0140-6736(18)32335-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Butler CD. Infectious disease emergence and global change: thinking systemically in a shrinking world. Infect Dis Poverty. 2012;1:5. doi: 10.1186/2049-9957-1-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zinsstag J, Schelling E, Wyss K, Mahamat MB. Potential of cooperation between human and animal health to strengthen health systems. Lancet. 2005;366:2142–2145. doi: 10.1016/S0140-6736(05)67731-8. [DOI] [PubMed] [Google Scholar]
  • 7.Zinsstag J, Schelling E, Waltner-Toews D, Whittaker M, Tanner M. CABI; Wallingford: 2015. One Health: the theory and practice of integrated health approaches. [Google Scholar]
  • 8.Gronvall G, Boddie C, Knutsson R, Colby M. One Health security: an important component of the global health security agenda. Biosecurity Bioterror. 2014;12:221–224. doi: 10.1089/bsp.2014.0044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Food and Agriculture Organization of the United Nations. World Organisation for Animal Health. WHO The FAO–OIE–WHO Collaboration: sharing responsibilities and coordinating global activities to address health risks at the animal-human-ecosystems interfaces. A tripartite concept note. 2010. https://www.who.int/foodsafety/zoonoses/final_concept_note_Hanoi.pdf
  • 10.Gostin LO, Friedman EA. The Sustainable Development Goals: One-Health in the world's development agenda. JAMA. 2015;314:2621–2622. doi: 10.1001/jama.2015.16281. [DOI] [PubMed] [Google Scholar]
  • 11.Hinchliffe S. More than one world, more than one health: re-configuring interspecies health. Soc Sci Med. 2015;129:28–35. doi: 10.1016/j.socscimed.2014.07.007. [DOI] [PubMed] [Google Scholar]
  • 12.Berthe FCJ, Bouley T, Karesh WB. The World Bank; Washington, DC: 2018. One Health: operational framework for strengthening human, animal, and environmental public health systems at their interface. [Google Scholar]
  • 13.Grace D. Review of evidence on antimicrobial resistance and animal agriculture in developing countries. 2015. https://assets.publishing.service.gov.uk/media/57a0897e40f0b649740000e0/EoD_Consultancy_June15_Ag_Related_AMR.pdf
  • 14.Thanner S, Drissner D, Walsh F. Antimicrobial resistance in agriculture. mBio. 2016;7:e02227–e02315. doi: 10.1128/mBio.02227-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Reich MR, Govindaraj R. Dilemmas in drug development for tropical diseases: experiences with praziquantel. Health Policy. 1998;44:1–18. doi: 10.1016/s0168-8510(98)00002-5. [DOI] [PubMed] [Google Scholar]
  • 16.Callaway E, Cyranoski D. Anti-parasite drugs sweep Nobel Prize in medicine 2015. Nat News. 2015;526:174. doi: 10.1038/nature.2015.18507. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary appendix
mmc1.pdf (67.2KB, pdf)

Articles from Lancet (London, England) are provided here courtesy of Elsevier

RESOURCES